Participated in Beacon Biosignals' $97M+ Series B financing upsizing.
OCT 2025
Beacon Biosignals is focused on transforming brain health through AI-driven neurotechnology, utilizing advanced EEG technology to enhance clinical trials and drug development for neurological and psychiatric conditions
Beacon Biosignals is focused on transforming brain health through AI-driven neurotechnology, utilizing advanced EEG technology to enhance clinical trials and drug development for neurological and psychiatric conditions.